Cargando…
Cognitive behaviour therapy for schizophrenia
Schizophrenia is one of the major and potentially severe mental illnesses. Even with best practices, there are limitations to the effectiveness of treatments that include medications for this disorder. Relapse rates are high and often those with the illness remain symptomatic and functionally impair...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292287/ https://www.ncbi.nlm.nih.gov/pubmed/22403587 http://dx.doi.org/10.3410/M4-6 |
_version_ | 1782225255754891264 |
---|---|
author | Addington, Jean Lecomte, Tania |
author_facet | Addington, Jean Lecomte, Tania |
author_sort | Addington, Jean |
collection | PubMed |
description | Schizophrenia is one of the major and potentially severe mental illnesses. Even with best practices, there are limitations to the effectiveness of treatments that include medications for this disorder. Relapse rates are high and often those with the illness remain symptomatic and functionally impaired. All the evidence suggests that individuals with schizophrenia do best with a combination of pharmacological and psychosocial intervention. One psychosocial treatment that has received much attention is cognitive behaviour therapy (CBT). This brief review will address what we know about the use and effectiveness of CBT at all phases of schizophrenia and its strengths, weaknesses and its future. |
format | Online Article Text |
id | pubmed-3292287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Faculty of 1000 Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-32922872012-03-08 Cognitive behaviour therapy for schizophrenia Addington, Jean Lecomte, Tania F1000 Med Rep Review Article Schizophrenia is one of the major and potentially severe mental illnesses. Even with best practices, there are limitations to the effectiveness of treatments that include medications for this disorder. Relapse rates are high and often those with the illness remain symptomatic and functionally impaired. All the evidence suggests that individuals with schizophrenia do best with a combination of pharmacological and psychosocial intervention. One psychosocial treatment that has received much attention is cognitive behaviour therapy (CBT). This brief review will address what we know about the use and effectiveness of CBT at all phases of schizophrenia and its strengths, weaknesses and its future. Faculty of 1000 Ltd 2012-03-01 /pmc/articles/PMC3292287/ /pubmed/22403587 http://dx.doi.org/10.3410/M4-6 Text en © 2012 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes |
spellingShingle | Review Article Addington, Jean Lecomte, Tania Cognitive behaviour therapy for schizophrenia |
title | Cognitive behaviour therapy for schizophrenia |
title_full | Cognitive behaviour therapy for schizophrenia |
title_fullStr | Cognitive behaviour therapy for schizophrenia |
title_full_unstemmed | Cognitive behaviour therapy for schizophrenia |
title_short | Cognitive behaviour therapy for schizophrenia |
title_sort | cognitive behaviour therapy for schizophrenia |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292287/ https://www.ncbi.nlm.nih.gov/pubmed/22403587 http://dx.doi.org/10.3410/M4-6 |
work_keys_str_mv | AT addingtonjean cognitivebehaviourtherapyforschizophrenia AT lecomtetania cognitivebehaviourtherapyforschizophrenia |